MGMT and glioblastoma: However, its clinical implication is less defined in elderly population due to the frequent exclusion of this subpopulation from clinical studies.[11] The aim of our study is to systematically review literature data on the clinical relevance of MGMT promoter status in elderly glioblastoma patients, and to seek valid evidence for its determinant role for treatment stratification.